We looked at 2021's six largest pre-IPO round recipients and how they’ve fared since going public. To put it mildly, most underperformed expectations...
Health, Wellness & Biotech
We here at Crunchbase love to talk about billions — billions in valuations, billions in revenue and billions in fundraising, even in a volatile year...
A lot happened in tech in 2022, much of it not particularly good. Bradley Tusk, co-founder and managing partner at Tusk Venture Partners, tackles the...
The sharp downturn in startup funding between 2021 and 2022 extends to venture-backed companies working on cancer therapies and diagnostics.
It was a weird week. Two of the top four rounds were actually large down rounds and a third came with “restructuring” and layoff news. Not exactly...
As we revisit a previously curated list of truly terrible SPAC performers, it’s clear they’re closing out the year at a particularly low point.
MasterControl, a decades old Salt Lake City-based company that provides software to manage the development of life science products, reached unicorn...
HistoSonics raised $85 million in funding led by Johnson & Johnson for a futuristic device it says could demolish tumors in patients with liver...
The current state of flux gives us the rare opportunity to build on telehealth successes.
November was another down month in venture, as VCs continue to pull back in a chilly market. Only three firms made a dozen or more deals, making us...
Pharmaceutical giant Amgen is wrapping 2022 with the largest pharmaceutical acquisition of the year (so far).
67.1K Followers